Executives On The Move: Biology Leader Exits Gilead, And Promotions At Mitsubishi And Sanofi
Exiting Gilead biology leader lands CSO post at blood cancer company Amphivena Therapeutics. Sanofi moves its Brazil general manager to head China Emerging Markets Business Unit and Mitsubishi Tanabe Pharma America promotes area director to VP, ops and strategy.
You may also be interested in...
News from around the biopharma sector and its efforts to meet the challenges posed by the coronavirus pandemic.
Coronavirus Update: More Companies Join Therapeutics Accelerator, FDA Delays AdCom For First NASH Drug
As the global number of COVID-19 cases exceeds 500,000 for the first time, more biopharma companies throw their weight behind Gates Foundation's drug-hunting initiative.
BIO hosts summit to support collaborations on coronavirus vaccines and therapeutics, Vir advances COVID-19 antibody candidates, Gilead renounces orphan status for remdesivir, BMS joins Pfizer in pushing back investor meeting, and ASCO goes virtual.